Simplex Trading’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Simplex Trading’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,600	Closed	-$19K	–	8389
2018 Q3	$19K	Buy	5,600 +1,647	+42%	+$5.94K	﹤0.01%	6016
2018 Q2	$14K	Buy	+3,953	New	+$19.2K	﹤0.01%	6151
2017 Q1	–	Sell	-7,057	Closed	-$38.7K	–	7190
2016 Q4	$41K	Sell	7,057 -21,841	-76%	-$119K	﹤0.01%	2370
2016 Q3	$153K	Buy	28,898 +8,344	+41%	+$45K	0.01%	1226
2016 Q2	$136K	Buy	20,554 +12,156	+145%	+$68K	0.01%	1263
2016 Q1	$39K	Buy	8,398 +1,800	+27%	+$7.18K	﹤0.01%	2188
2015 Q4	$33K	Buy	+6,598	New	+$31.3K	﹤0.01%	2276
2015 Q3	–	Sell	-1,888	Closed	-$12.6K	–	6583
2015 Q2	$18K	Buy	1,888 +1,285	+213%	+$13.8K	﹤0.01%	2587
2015 Q1	$7K	Buy	+603	New	+$7.75K	﹤0.01%	3287

Simplex Trading's KERX Position: Q4 2018 in Review

Simplex Trading sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 5,600 shares — an estimated $19K sold.

Simplex Trading first reported a position in KERX in Q1 2015 and held it in 9 quarters. The position peaked at $153K in Q3 2016. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Simplex Trading reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Simplex Trading sold 5,600 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $19K.
Simplex Trading first reported a position in Keryx Biopharmaceuticals Inc in Q1 2015 and held it in 9 quarters.
Simplex Trading's Keryx Biopharmaceuticals Inc position peaked at $153K in Q3 2016.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Simplex Trading's 13F filing for Q4 2018, filed 16 Jan 2019.